Physician profile
Khalid Najib
NPI 1558626077
$26,476.64
in general payments reported to CMS, 2019-2025
29 companies · $915 in 2025
The $915 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $748 · 2021: $2,719 · 2022: $13K · 2023: $5,880 · 2024: $1,979 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,322 · Food and Beverage: $4,180 · Grant: $272 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,321.91 |
| Food and Beverage | $4,180.38 |
| Grant | $271.74 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,160.77 | 2021-2025 | Corevalve Evolut R, Symplicity G3, V-Loc 180 |
| Abbott Laboratories | $3,243.88 | 2019-2025 | Perclose Prostyle, Supera, Optis |
| Edwards Lifesciences Corporation | $2,145.77 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Penumbra, INC. | $2,048.12 | 2020-2024 | Indigo System, Ruby Coil |
| Boston Scientific Corporation | $1,031.45 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Cardiovascular Systems INC. | $928.01 | 2021-2022 | |
| Philips North America LLC | $865.56 | 2021-2025 | IV Other |
| Inari Medical, INC. | $681.82 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Incorporated | $616.38 | 2023 | Zilver Ptx |
| Abiomed | $529.67 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $409.27 | 2019-2020 | |
| Cook Medical LLC | $387.73 | 2023 | Zilver Ptx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $241.40 | 2021-2024 | Lifevest |
| Heartflow, INC. | $170.22 | 2022-2023 | Ffrct |
| Novartis Pharmaceuticals Corporation | $139.54 | 2022-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $133.74 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $119.79 | 2019-2023 | Farxiga |
| Cardiva Medical, INC. | $114.73 | 2023 | Cardiva Vascade 6/7f Vcs |
| Chiesi USA, INC. | $108.14 | 2022-2023 | Kengreal, Cleviprex |
| Alnylam Pharmaceuticals INC. | $106.28 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $99.11 | 2022-2023 | Xarelto |
| Ethicon US, LLC | $38.81 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Pfizer INC. | $31.66 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $27.63 | 2020-2021 | |
| Shockwave Medical, INC | $27.19 | 2022 | |
| Bridgebio Pharma, INC. | $19.39 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $17.75 | 2025 | Shingrix |
| Merck Sharp & Dohme LLC | $16.75 | 2023 | Verquvo |
| Teleflex LLC | $16.08 | 2023 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Najib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.